약제 연관 소화성궤양의 임상 진료지침 개정안 2020

The Korean guidelines for nonsteroidal anti-inflammatory drug (NSAID)-induced peptic ulcers were previously developed under co-work with the Korean College of Helicobacter and Upper Gastrointestinal Research and Korean Society of Gastroenterology at 2009. On the other hand, the previous guidelines w...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:The Korean journal of gastroenterology 2020, 76(3), , pp.108-133
Hauptverfasser: 주문경, Moon Kyung Joo, 박찬혁, Chan Hyuk Park, 김준성, Joon Sung Kim, 박재명, Jae Myung Park, 안지용, Ji Yong Ahn, 이봉은, Bong Eun Lee, 이정훈, Jeong Hoon Lee, 양효준, Hyo-joon Yang, 조유경, Yu Kyung Cho, 방창석, Chang Seok Bang, 김범진, Beom Jin Kim, 정혜경, Hye-kyung Jung, 김병욱, Byung-wook Kim, 이용찬, Yong Chan Lee
Format: Artikel
Sprache:kor
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
Beschreibung
Zusammenfassung:The Korean guidelines for nonsteroidal anti-inflammatory drug (NSAID)-induced peptic ulcers were previously developed under co-work with the Korean College of Helicobacter and Upper Gastrointestinal Research and Korean Society of Gastroenterology at 2009. On the other hand, the previous guidelines were based mainly on a literature review and expert opinions. Therefore, the guidelines need to be revised. In this study, a guideline development committee for drug-induced peptic ulcers was organized under the Korean College of Helicobacter and Upper Gastrointestinal Research in 2017. Nine statements were developed, including four for NSAID, three for aspirin and other antiplatelet agents, and two for anticoagulants through de novo processes based on evidence-based medicine, such as a literature search, meta-analysis, and the consensus was established using the modified Delphi method. The primary target of this guideline was adult patients taking long-term NSAIDs, aspirin, or other antiplatelet agent and anticoagulants. The revised guidelines reflect the consensus of expert opinions and are intended to assist relevant clinicians in the management and prevention of drug-induced peptic ulcers and associated conditions. (Korean J Gastroenterol 2020;76:108-133)
ISSN:1598-9992
2233-6869
DOI:10.4166/kjg.2020.76.3.108